| 发明名称 |
NEW PI3K/AKT/MTOR INHIBITORS AND PHARMACEUTICAL USES THEREOF |
| 摘要 |
The invention relates to new PI3K/AKT/m TOR inhibitors and their use for the prevention and/or the treatment of a disease selected from the group consisting of: inflammatory diseases, autoimmune diseases, neurodegenerative diseases, cancers, transplant rejection, diseases characterized by a premature aging and tuberous sclerosis. |
| 申请公布号 |
US2016244424(A1) |
申请公布日期 |
2016.08.25 |
| 申请号 |
US201415025086 |
申请日期 |
2014.09.24 |
| 申请人 |
UNIVERSITE DE RENNES 1 ;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) ;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
发明人 |
JEAN Mickael;FOUQUE Amélie;LEGEMBRE Patrick;VAN DE WEGHE Pierre |
| 分类号 |
C07D311/60;C07D409/04;C07D495/04;C07D493/10;C07D335/06;C07D407/04 |
主分类号 |
C07D311/60 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A compound having one of the following formulae:or its pharmaceutically acceptable salts, hydrates or hydrated salts or its polymorphic crystalline structures, racemates, diastereomers or enantiomers. |
| 地址 |
Rennes Cedex FR |
